These results highlight a novel miR‐134‐CREB‐BDNF‐mediated mechanism in regulating synaptic plasticity and associativity in the AD hippocampus and miR‐134‐5p can be proposed as a potential target for the diagnosis of AD and the development of appropriate therapeutic agents for AD. The gene discussed is CREB1; the disease is Alzheimer disease.